Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

08/11/2022 04:30

Nov 8 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.82               37.59            76.40    
                 (-2.0 pct)          (+2.2 pct)       (+0.5 pct)  
  Operating          8.21                9.04            15.00    
                 (-9.2 pct)          (-7.6 pct)       (-12.1 pct) 
  Recurring          8.56                9.29            15.50    
                 (-7.9 pct)          (-7.2 pct)       (-11.6 pct) 
  Net                5.96                6.72            12.00    
                 (-11.3 pct)         (-7.0 pct)       (+25.7 pct) 
  EPS            158.34 yen          176.24 yen       320.23 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T